NRX Pharmaceuticals's total assets for Q4 2023 were $3.79M, a decrease of -48.22% from the previous quarter. NRXP total liabilities were $18.86M for the fiscal quarter, a -1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.